Dear friends
Dr. Mira Shiva informs that
A company in India is developing genetically engineered Brinjal incorporating the Bacillus thuringiesis gene.
The Antibiotic Resistant Marker being used for Bt Brinjal is NEOMYCIN . Horizontal transfer of genes & Genetic pollution & other Public Health Concerns need to be addressed as Biosafety studies done by the Company are inadequate. The GEAC Meets on 14th Jan 09.
All of you need to comment on this proposal in this space so that Dr. Mira Shiva takes it up at the appropriate forum.
* A blog of Indian Initiative for Management of Antibiotic Resistance (IIMAR) managed by Dr. A. J. Tamhankar
No comments:
Post a Comment